ð¥çä¹³æåã§é«éœ¢æãå€§è ¿éªšè¿äœéšéªšæèµ·ãã
ãYouTubeæŽæ°ããŸãã
âââââââââ
N Engl J MedïŒ2020; 382:644-654ïŒã«ãçä¹³ãšå¥åº·ãã®ç·èª¬ããããŸãããèè ã¯ããŒããŒã倧åŠã®å ¬è¡è¡çã®ãã¯ã¿ãŒãã¡ã§ããäœããªãèªã¿å§ããã®ã§ãããããŸãã®æå€ãã«ã²ã£ããè¿ãã»ã©é©ããŸãããæ倧ã®ãã€ã³ãã¯ãçä¹³æåã§æçµèº«é·ã䌞ã³ãããé«èº«é·ã¯é«éœ¢æãå€§è ¿éªšè¿äœéšéªšæããã®ä»ã®éªšæãšåŒ·ãçžé¢ãããïŒãã§ãã
ãææ¥æã§ã®çä¹³æåéãšæçµé«èº«é·ãšã¯çžé¢ããããŸãããšãããçä¹³ããããã飲ãã§é«èº«é·ã«ãªããšåŸå¹Žãé«éœ¢ãšãªã£ããšãã«ãªããšå€§è ¿éªšè¿äœéšéªšæããã®ä»ã®éªšæãèºå¡æ çããããªã©ã®ãªã¹ã¯ãå¢å ãããšããã®ã§ããé«èº«é·èªäœã«ãããããªãªã¹ã¯ããããšããããšã«é©ããŸãããæ é€ç¶æ ãæªãçºå±éäžåœã§ã¯å°å æã®çä¹³æåã¯ç¡è«ãæå³ããããŸãããããå é²åœã§çä¹³ã1æ¥3æ¯ä»¥äžåãããšã¯æšå¥šããªããšããã®ã§ãã
ãN Engl J Medãçä¹³ãšå¥åº·ïŒç·èª¬ïŒãæéèŠç¹ã¯æ¬¡ã®8ç¹ã§ãã
â ææ¥æã®çä¹³é«çšéæåã§æçµèº«é·ã䌞ã³ã
â¡ææ¥æã®çä¹³æåã¯ã³ãã1æ¯/æ¥ããšã«é«éœ¢æã®å€§è
¿éªšè¿äœéšéªšæãªã¹ã¯ã9%å¢å ïŒ
â¢é«èº«é·ã¯å€§è
¿éªšè¿äœéšéªšæããã®ä»ã®éªšæãèºå¡æ çããããå¢ãã
â£ã«ã«ã·ãŠã æåã¯éªšå¡©éã倧è
¿éªšè¿äœéšéªšæãæ¹åããªã
â€å°å
ã¯ãäœèèªä¹³è£œåã§äœéãå¢å ããããšãŒã°ã«ãã¯æžéã«æå¹ãã
â¥çä¹³æåã¯åç«è
ºãããåå®®å
èãããšçžé¢
âŠå
šæ»äº¡çãšèçœæºã®é¢ä¿ïŒå å·¥èïŒåµïŒèµ€ãèïŒçä¹³ïŒéïŒé¶ïŒæ€ç©
â§çä¹³äžèæ§å
ã¯è±ä¹³ã§ã¢ã¬ã«ã®ãŒçç¶ãæ¹åãã
Â
ð¥ææ¥æã®çä¹³é«çšéæåã§æçµèº«é·ã䌞ã³ã
ãããžãŒããšæã£ãã®ã¯ã2007幎ãã2012幎ã«ãããŠã®ç 究ã«ãããšãååã«æ é€ã足ããŠããŠããçä¹³ãäœåã«é£²ãããšã«ããé·è»žæ¹åã®æé·ãä¿é²ããæçµèº«é·ã䌞ã³ããšããã®ã§ãã
ð¥ãããããã°ç ä¿®å»ã®ãšãã身é·190cmãè¶ ããå çãããããã®ã§ãããå°å æã®é£ç掻ãèãããšããããšã«ããçä¹³ã奜ãã§æ¯æ¥1ïœ2L飲ãã§ãããšã®ããšã§ããããã ããŸã身é·ã䌞ã³ããšããªãŒãã³ãææãšè©±ããšããã€ãç«èã«ãªã£ãŠãããçã«ãªãè¯ããªããšã®ããšã§ããã
ãð¥ãã®èº«é·ã®äŒžé·ãç¹æ®ãªã¢ããé žïŒç¹ã«leucinãisoleucineãvalineïŒãèçœååãã«ã¢ã³ãªã©ã«ããã®ãã¯äžæã§ããleucinãisoleucineãvalineã¯è¡æŒ¿ã€ã³ã¹ãªã³æ§æé·å åïŒIGFïŒ-â ãå¢ãããæé·ãã«ã¢ã³ã®åæ³ãä¿ããŸããleucinã¯ç¹ã«åºä¹³åç©ã®rapamycin (mTOR)çµè·¯ã掻æ§åã现èå¢æ®ãä¿ããŠã¢ãããŒã·ã¹ïŒçŽ°èã®èªæ®ºïŒãæå¶ããã®ã ããã§ãã
ð¥ææ¥æã®çä¹³æåã¯ã³ãã1æ¯/æ¥ããšã«é«éœ¢æã®å€§è
¿éªšè¿äœéšéªšæãªã¹ã¯ã9%å¢å ïŒ
ãç·èª¬ã®äžã«äžç40ã«åœã»å°åã®çä¹³æåéãšå€§è
¿éªšè¿äœéšéªšæé »åºŠã®çžé¢ã°ã©ãããããŸããå欧諞åœïŒã¹ãŠã§ãŒãã³ããã«ãŠã§ãŒããã³ããŒã¯ããã£ã³ã©ã³ãïŒã¯çä¹³æåéãå€ãã«ããããããã倧è
¿éªšè¿äœéšéªšæã倧å€å€ãã®ã§ããäžæ¹ãã¢ãžã¢è«žåœïŒã€ã³ããã·ã¢ããã¬ãŒã·ã¢ãäžåœãéåœãæ¥æ¬ãå°æ¹ŸïŒã¯çä¹³æåéãå°ãªãã®ã§ãã倧è
¿éªšè¿äœéšéªšæãå°ãªãã®ã§ããçä¹³æåéãšå€§è
¿éªšè¿äœéšéªšæã®çºçã¯æãããªæ£ã®çžé¢ããããŸãã
Â
ãð¥å°çãååœã®å¹³å身é·ã調ã¹ããšãããå欧ååœã§ç¹ã«ç·æ§ã¯å€§å€èº«é·ãé«ããç·æ§å¹³å身é·ã¯ã¹ãŠã§ãŒãã³180cmããã³ããŒã¯180.6cmããã«ãŠã§ãŒ179.9cmãã¢ã€ã¹ã©ã³ã181.7cmã§ãããæ°å¹Žåã¢ã€ã¹ã©ã³ããæ è¡ãããšããèã®äœãããããæ¥æ¬äººããèŠããšçãç¡é§ã«èãé«ãããªãšæããŸããã
ã
ð¥ã¢ã€ã¹ã©ã³ãåéšã§è¥¿æŠ1700幎ããã®æ°å®¶ãèŠåŠããŸãããå¯ããé²ãããå£ã¯æº¶å²©ããããã¯ã«ããŠåã2mããããšããå±æ ¹ã¯èãæã§èºããŠãã®äžã«åããã¶ããŸããã¢ã€ã¹ã©ã³ãã¯æ¥µåã§æ£®æããªããææšã¯æµ·å²žã®æµæšã䜿ãã®ã§ææšå©çšã¯éãããŸããå°æã®ç±ãå»äžãéããŠåéšå±ã«è¡ãæž¡ãããã«ãªã£ãŠããŸãããçæã¯éŠ¬ç³ãçç³ã䜿ããŸãã
Â
ð¥ãé©ããã®ã¯ãããã®å°ããã§ãããã¬ã€ãã®è©±ã ãšæã¯æ é€ãæªããŠã¢ã€ã¹ã©ã³ã人ã¯èº«é·ãäœãã£ããšã®ããšã§ãããéèã¯ãžã£ã¬ã€ã¢ããããããªãã¯ã€ã³ã¯ã¹ãã€ã³ããèŒžå ¥ããŸãããèã¯ãã¿ãŒãã€ããéã§ããé žæ§ã®æ°Žã«æŒ¬ããŠä¿åããŸããã
ã
ð¥ã¬ã€ãã£ãã¯éå€ã®å°ç±çºé»æãèŠåŠãããšããäºæ人圢ãå±ç€ºãããŠããŸãããå°ãããšãã7ã€ã®ã¿ãŒãã³ïŒæµäœã§è»žãå転ãããååæ©ïŒã®ãã¡6å°ãäžè±éå·¥ã1å°ãæ±è補ã ãšã®ããšã§ãããããããã°ç©ºæž¯ã«æ¥æ¬äººå®¶æãããŠé§åšå¡ã®ããã§ããã
Â
ð¥ãããã§ã¯çºé»ã ãã§ãªãå°äžæ°kmãã200âã®ç±æ°Žããã¿äžããŠã¬ã€ãã£ãã¯ãŸã§27kmãçŽåŸ70cmãããªãšãã¬ã³å å·¥ããã管ã§éããŸãã27kméããš91âã«ãªãæçµçã«å®¶åºã«éãããšãã¯60âã§ããæž©æ°Žã¯ç¡«é»èãã®ã§ãã䜿ãæŸé¡ã§ããæž©æ°Žã¯å®¶åºã§äœ¿çšããåŸãéè·¯ã«æµãå¬ã®éã«ç©éªããªãããã«ãããããŠæµ·ã«æµããŸããæž©æ°Žã«ããããããéèãæ œå¹ããããªããšæ¬§å·ãžèŒžåºãããŠããŸããã¢ã€ã¹ã©ã³ãã®å¹³åæåã¯50äžåãããã§ãã
ã
ð¥ã¢ãžã¢ã®ç·æ§å¹³å身é·ã¯ã€ã³ããã·ã¢162.4cmãäžåœ164.8 cmãæ¥æ¬171.2cmãéåœ175.3cmã§ããæ¥æ¬å¥³æ§ã¯158.8cmãéåœå¥³æ§162.6cmã§éåœäººã®æ¹ãã¹ã¿ã€ã«ã¯è¯ãããã§ãã
ã
ð¥çä¹³ã«ãã£ãŠé«èº«é·ã«ãªããšããªãå€§è ¿éªšè¿äœéšéªšæãå¢ããã®ããã®çç±ã¯æžããŠãããŸãããã骚ç²é¬çã§é«èº«é·ãšãªããšè»¢åãããšãã®è¡æã¢ãŒã¡ã³ãã倧ããããã§ããããïŒ
ã
ð¥ãã®çžé¢ã¯ãã¿ãã³Dã人皮ãªã©ã®äº€çµ¡å åïŒconfounding factorsïŒåœ±é¿ãããã®ãããããªããšã®ããšã§ããã
ã
ð¥ç·æ§ã§ã¯ææ¥æã®çä¹³æåãã³ãã1æ¯/æ¥å¢ããããšã«é«éœ¢æã®å€§è ¿éªšè¿äœéšéªšæãªã¹ã¯ããªããš9ïŒ å¢å ããŸããææ¥æã®çä¹³é«æåãšé«éœ¢æã®å€§è ¿éªšè¿äœéšéªšæãçžé¢ããã®ã§ããäžæ¹ã女æ§ã§ã¯çä¹³æåãšå€§è ¿éªšè¿äœéšéªšæã«çžé¢ã¯ãããŸãããã€ãŸãããŒã¿ããã¯ãç·æ§ã®ææ¥æã§ã®çä¹³é«æåã¯é«éœ¢åæã®éªšæãªã¹ã¯ãå¢ãã®ã§ãã
ã
ð¥ãšããããã§ãå°å æã®çä¹³æåã®å¹æã¯ããåãããŸãããç¡è«ãæ¯ä¹³ãå©çšã§ããªããã°ä¹³å ã«ã¯äŸ¡å€ããããŸããããŸãçºå±éäžåœã§ã¯çä¹³ã®å©ç¹ã¯å€§ããã§ããããçä¹³ã¯æé·ãå éãæçµèº«é·ã䌞ã³ãŸãããããé«èº«é·ã¯ãªã¹ã¯ãšã¡ãªããããããŸããæ é€ãååãªå°åã§çä¹³é«æåã¯é«éœ¢æã®éªšæãªã¹ã¯ãå¢å ããã®ã§ãã
ãçºå±éäžåœã§ã¯çä¹³ã¯å°å ã«æå³ãããããå é²åœã§ã¯éå°æåã¯å©çããªã害ãããããšããããšãèŠããŠãããŸããããèè ã®æèŠã§ã¯ãçä¹³ã3æ¯ä»¥äžé£²ãããšã¯æšå¥šããªãããšã®ããšã§ãã
Â
ð¥é«èº«é·ã¯å€§è
¿éªšè¿äœéšéªšæããã®ä»ã®éªšæãèºå¡æ çããããå¢ãã
ãé«èº«é·ã§å¿è¡ç®¡ãªã¹ã¯ã¯æžããŸããã倧è
¿éªšè¿äœéšéªšæãå€ãã®éªšæãèºå¡æ çããããå¢ããŸããä»ãŸã§é«èº«é·ã«ãã害ãªããŠèããããšããªãã£ãã®ã§ãã倧å€é©ããŸããã
ãããããã°ã骚ç²é¬çã§ã¯BMDïŒBone Mineral Densityã骚塩éïŒãšäžçä¿å¥æ©é¢ïŒWHOïŒã®FRAX質å祚ã®2ã€ãåãããŠãæ²»çãéå§ããã決ããŸãããã®WHOã®FRAXã«ã¯å¿ ã身é·ãäœéïŒBMIïŒãå ¥åããŸããç©ããŠçŽ°ãè人ã¯æããã«éªšæãªã¹ã¯ãé«ãããã§ããå°å€ªãã®ãã°ãããã¯æå€ã«äžå€«ãªã®ã§ãããããããšçããåã³ãŸãã
ãææ°ã®éªšç²é¬çæ²»çã«ã€ããŠã¯é¢é£ãªã³ã¯1ãã芧ãã ããã
ããŸãšããŸããšãçä¹³æåã¯æçµèº«é·ã䌞ã°ãããé«èº«é·ã¯å€§è ¿éªšè¿äœéšéªšæããã®ä»ã®éªšæãšåŒ·ãçžé¢ãããããšããããšã§ãã
Â
ð¥Â ã«ã«ã·ãŠã æåã¯éªšå¡©éã倧è
¿éªšè¿äœéšéªšæãæ¹åããªã
ãã€ãæè¿ãŸã§ã«ã«ã·ãŠã ïŒãã¿ãã³Dã¯ã骚ç²é¬çäºé²ã«åœå
ã§ãããæäžãããŠããŸãããé¢é£ãªã³ã¯1ã®Lancetã®éªšç²é¬çç·èª¬ã§å€§å€é©ããã®ã¯ããªããšãã«ã«ã·ãŠã ïŒãµããªã§500mgæšå¥šïŒïŒãã¿ãã³Dã®å¹æã¯ã¯ã£ããããªãããšããç¹ã§ãã
ã
ð¥äººäœã£ãŠãªããªãçè«éãã«ã¯ãããªããã®ã ãªãšãäžæè°ã«æã£ãŠããã®ã§ãããä»åã®N Engl J Medç·èª¬ãçä¹³ãšå¥åº·ãã§è¬ã解ããŸããããã«ã«ã·ãŠã æåã®éŸå€ã¯äœããéå°æåã¯äœãæå³ããªããã®ã§ããç«ã«ãµã³ãããããŠã1å¹ç®ã¯ãããŒãé£ããã©2å¹ä»¥äžã ãšãã£ãœãåãã®ã§ãã
ã
ç«ãšããã°ä»¥åãç é¢ããã®åž°ãéã§ã暪ãåããŠã¯ã·ã£ãããããšãããããµããšé³ãããŸãããäœã ãããšèŠããšãããèµ€ãé²ç«çšæ°Žã®ç®±ã®äžã§ç«ãå¯ãŠããã®ã§ããã¯ã·ã£ãã«é©ããŠèäžããèœã¡ãã®ã§ããç«ãèäžããèœã¡ãããšããããšããããšã¯ããã®ãšãåããŠç¥ããŸããã
ã
以åãåäŒè±ã§å€§ããªæšã®äžã§ç¿ãæ»ãã§ããŸãããç¶æ³ããã¯æšããèœã¡ãŠé éšå€å·ãèµ·ãããããã§ããããæ¬åœã«ç¿ãæšããèœã¡ããã ããšå€§å€é©ããŸããã
ã5件ã®ã¡ã¿è§£æã§6,740人èš814件ã®æ€äœéªšæã§ã«ã«ã·ãŠã ãšãã©ã»ããæ¯èŒãããšãããæ€äœéªšææžå°ã«ãªããšå·®ããããŸããã§ãããçžå¯Ÿãªã¹ã¯ïŒRR ïŒ0.92ã95%CI 0.81ïœ1.05ïŒããå€§è ¿éªšè¿äœéšéªšæã¯ãã©ã»ããããéã«ã«ã«ã·ãŠã æå矀ã®æ¹ãå€ãã£ãã®ã§ãïŒRR1.64ãå 1.02ïœ2.65ïŒã
ãã«ã«ã·ãŠã æšå¥šæåéã¯ãWHOã§ã¯500mg/æ¥ãè±åœã§ã¯700mg/æ¥ã§ããããã«å¯Ÿããç±³åœã§ã¯50æ³ãŸã§ã¯1,000mg/æ¥ã51ïœ70æ³ã¯ç·æ§1,000mgã女æ§1,200mgã70æ³ä»¥äžã¯ç·å¥³ãšã1,200mgãšãããŠããŸãã
ããã®ç±³åœã®æšå¥šé1,000mg/æ¥ã¯2007幎ã10幎ã®155人ã®æ人ã§ã®ã«ã«ã·ãŠã æåãææ³ãã©ã³ã¹ã®ç 究ã§741mg/æ¥ã ã£ãããšã«ãããŸãããããããã®ç 究ã¯2ïœ3é±ã®çæéã§è¡ããããã®ã§ããããŸãæ¥ããã«ã«ã·ãŠã ãé«æåããŠãã人ãã¡ã§ãã
ãäžæ¹ãæ®æ®µããã«ã«ã·ãŠã æåéãå°ãªããã«ãŒäººç·æ§ã§ã¯ãªããš200mg/æ¥ã§ãã©ã³ã¹ãéæããããšããã®ã§ããã€ãŸããã«ã«ã·ãŠã æåãå°ãªãå Žåãäœã¯ã«ã«ã·ãŠã æåéãå¢ãããïŒupregulateïŒïŒããšããæå³ã§ããå€æ¥ã«æ¥ãŠããå€åœäººå¥³æ§ã«ããã®ããããªã«åž°ã£ãŠããïŒããšèãããããå çãããªãããªãããã«ãŒïŒããšèšãããŸãããäœå¹Žãåž°ã£ãŠãªããã©å®¶æãšã¯æ¯é±ã¹ã«ã€ãã§è©±ããŠããããã§ããã©ãããã®èŸºãã®åœã®äœçœ®é¢ä¿ãããåãããŸããã
ã骚æã®ä»£çã«éªšå¡©éãçšããã©ã³ãã åæ¯èŒè©ŠéšïŒRCTïŒã§ã«ã«ã·ãŠã 1,000ïœ2,000mg/æ¥ã§ãã©ã»ãã«æ¯ã¹éªšå¡©éã¯1ïœ3ïŒ å¢å ããŸããããããããç¶æãããã°å€§ããªæå³ããããŸããããã1幎åŸã«ã¯ãéçµååŸããããã¯éçµåŸã®å¥³æ§ã§ã¯ãã©ã»ããšåãã«ãªã£ãŠããŸãããã«ã«ã·ãŠã æåãããããšããã®ããããªå·®ã¯éããã«ãªããªãã®ã§ããã§ãããç¶ç¶æéã1幎以äžã®ãã©ã€ã¢ã«ã¯ããŸãæå³ããªããã誀解ãæãïŒmisleadingïŒãšããã®ã§ãã
ãç±³åœç·å¥³1äžäººã®æ€èšã§ã¯ãã«ã«ã·ãŠã æåéãšå€§è ¿éªšè¿äœéšéªšå¡©éãšã¯çžé¢ããªãããŸãã«ã«ã·ãŠã 555mgïœ1, 100mg/æ¥æåã¯å€§è ¿éªšè¿äœéšéªšæãªã¹ã¯ãšé¢ä¿ããããŸããã§ãããä»ã®ã¡ã¿è§£æã§ãçä¹³1.5æ¯ïŒservingïŒ/é±ä»¥äžæåãŸãã¯é ªè£œåæåã¯ç·å¥³ã§å€§è ¿éªšè¿äœéšéªšæãšé¢ä¿ããããŸããã§ãããçµå±ïŒoverallïŒãé ªè£œåã®é«æåã¯å€§è ¿éªšè¿äœéšéªšæãæ¹åããªãã®ã§ãã
ãå°å ã§ã¯æé·ã«positive balanceãå¿ èŠãªããšãããã«ã«ã·ãŠã æåéã®æšå®ãé£ããã®ã§ãã女å ã§ã¯ã«ã«ã·ãŠã ãã©ã³ã¹ã¯400mg/æ¥ä»¥äžã§ããã©ã¹ã«ãªãã4ïœ8æ³ã§ã«ã«ã·ãŠã æåéã¯éªšå¡©éãšé¢ä¿ããªããšããã®ã§ããRCTã§ã«ã«ã·ãŠã æå800mg以äžã®å°å ã«ãæ¯æ¥çä¹³3人åã18ã«ææåããŠããããŸããã骚塩éã«å·®ã¯ãããŸããã§ããã
ããããã£ãŠå°å æã®ã«ã«ã·ãŠã é«æåã§äººçã®éªšãã³ã¯ãã§ããããã§ã¯ãªãã®ã§ãã人äœã¯çµå±ãã«ã«ã·ãŠã æå200mg/æ¥çšåºŠã§ããªããšãããŠããŸãã®ã§ããã«ã«ã·ãŠã æåã®éŸå€ã¯äœãããã以äžæåããŠã骚塩éã«é¢ä¿ããããŸããã
5. å°å
ã¯ãäœèèªä¹³è£œåã§äœéãå¢å ããããšãŒã°ã«ãã¯æžéã«æå¹ãã
ãå°çãå°äžåŠçã®ããã¯åŠæ ¡ã§è±èç²ä¹³ãšããã®ã飲ãŸãããŸãããçãŸãããšèšã£ãŠããŸãããå°çã¯åãã§é£²ãã§ããŸããããããŸããã®éŸå€ãäœãã£ãã®ã§ããããã
ã1äž2,829人ã®ææ¥æå ç«¥ã§3幎éã®äœèèªä¹³è£œåæåã¯BMIå¢å ãšçžé¢ããŸãããå šä¹³ãé ªè£œåã§ã¯çžé¢ããããŸããã§ããããªããšäœèèªä¹³è£œåã®æ¹ãéã«å€ªããšããã®ã§ããããã¯å šäœã®ãšãã«ã®ãŒæåéå¢å ã«ããã®ãããããªããšã®ããšã§ããçµå±ãããŒã¿ããã¯äœèèªä¹³è£œåã¯æšå¥šããŸããã
ã1976幎ã«è±åœã§ã581æ ¡ã®å°åŠæ ¡ã§3幎éæŒã«ïŒãªã³ã¹ïŒ198gïŒã®çä¹³æå矀ãšéæå矀ãšã®æ¯èŒã§ã3幎åŸã®äœéã«å·®ã¯ãããŸããããç乳矀ã¯è¥å¹²èº«é·ãé«ããªããŸããã
ã29件ã®RCTã§ã¯ãçä¹³ãé ªè£œåæåãšäœéã«çžé¢ã¯ãããŸããã§ããããã 3件ã®å€§èŠæš¡ã³ããŒãã§ãšãŒã°ã«ããšæžéã«çžé¢ããããŸããããšãŒã°ã«ãã¯è¥æºäºé²ãè žå 现èå¢ã®ç¶æã«æå³ããããããããŸããããã ããšãŒã°ã«ãæå矀ã¯ãæ®æ®µããå¥åº·ã¹ã¿ã€ã«ã«æ°ã䜿ã人ãã¡ã ãããããããŸããã
ãçµè«ã¯ãå°å ã§ã¯äœèèªä¹³è£œåã®æåã¯å šä¹³ãããäœéãå¢å ãããæšå¥šãããŸããããšãŒã°ã«ãã¯æžéã«æå¹ãããããŸããã
6. çä¹³æåã¯åç«è
ºãããåå®®å
èãããšçžé¢
ãçä¹³ã®æåéãšä¹³ãããåç«è
ºããããã®ä»ã®ãããšã¯åŒ·ãçžé¢ããŸãããçä¹³ã«ããè¡æŒ¿IGF-IïŒïŒãœããã¡ãžã³CïŒãäžæãããããããããŸããããªãã«ããã欧å·ã§ã¯çãžã®ãœãããããã³ïŒIGF-IãäžæããïŒæäžãçŠæ¢ããŠããŸãã
ãååãã³ããŒãã§ã¯ãçä¹³ã¯åç«è ºããïŒç¹ã«äŸµè¥²æ§ãèŽæ»çåç«è ºããïŒã®ãªã¹ã¯ãšäžè²«ããŠçžé¢ïŒconsistently associatedïŒããŸãããä¹³ãããšã¯ããã»ã©çžé¢ããŸããã§ããã
ãé ªè£œåã®ç·æåéãšãç¹ã«éçµåŸããã«ã¢ã³æ²»çãåããŠããªã婊人ã®åå®®å èãããšçžé¢ããŸããããããã¯é ªè£œåäžã®æ§ãã«ã¢ã³ã«ããã®ãããããŸãããé ªè£œåæåãšå šæ»äº¡çã®éã«çžé¢ã¯ãããŸããã
7. å
šæ»äº¡çãšèçœæºã®é¢ä¿ïŒå å·¥èïŒåµïŒèµ€ãèïŒçä¹³ïŒéïŒé¶ïŒæ€ç©
ã以åãå
¥é¢äžã®ããããããæåãã«ã¹ã¿ã€ã³ããšããéèªãèªãã§ããŸãããä¹³ç蟲家ã®æ©é¢èªã§ãããããªéèªãååšãããšããããšã«é©ããŸããããããããæ¥æ¬æŽåœ¢å€ç§åŠäŒéèªããªããŠã®ãäžè¬äººã«ãšã£ãŠã¯ãæåãã«ã¹ã¿ã€ã³ã䞊ã¿ã®é©ããªãã ãããªãšæããŸããã
ããªãã§ããã®ããããã1965ïŒæå40ïŒå¹Žã®çã®åè©äŒã§å šåœ1äœã«ãªã£ãã®ã ããã§ããçä¹³ãæ¡ãã®ã¯ãã«ã¹ã¿ã€ã³ãããžã£ãŒãžãŒçïŒè±åœç£ãè¶è²ã§å°åããã¿ãŒåãèèªãå€ãïŒãèçã¯é»æ¯åçãäžè¬çã ããã§ããæŸåçãé»æ¯åçã§ãã
ã話ããèããããšããã30幎åãŸã§å®¶ã§ä¹³çãæ倧17é 飌ã£ãŠããŠç乳販売ãããŠãããšããã®ã§ãããããåççïŒåœæïŒãäžå°é ªèŸ²å®¶ã®ç乳販売ãçŠæ¢ãããã®ä»£ããã森氞çä¹³ãã®è²©å£²ãèš±å¯ããããšã®ããšã§ãããå€åãã®çä¹³ã®äžè¡çããããäžå°é ªèŸ²å®¶ã®è²©å£²ãçŠæ¢ããã®ã§ãããã
ãçä¹³ã®æ®ºèã¯ãã¹ããŒã«èæ¡ã®äœæž©æ®ºèæ³ïŒPasteurizationïŒãšãã£ãŠã63âã§30åéããŸãã¯72ïœ78âã§15ç§é殺èããŠãã«ã»ã©ç ãçµæ žèã®æ®ºèãè¡ããŸããã¯ã€ã³ã®æ®ºèããã®æ¹æ³ã§ã¢ã«ã³ãŒã«ãé£ã°ããã«é¢šå³ãä¿ã¡ãªãã殺èããã®ã ããã§ããããããã°ãã€ãã³ã²ãŒã«ã®æ»å ã¯ãã«ã»ã©ç ïŒBrucellosisïŒã ã£ãããã§ãã
ãå šæ»äº¡çãšèçœæºãšã®é¢é£ã¯ãå å·¥èïŒåµïŒèµ€ãèïŒçä¹³ïŒéïŒé¶ïŒæ€ç©ã®é ã§ããææªã®é£ç©ãå å·¥èïŒãã ããœãŒã»ãŒãžãããŒã³ã³ããã³ããŒã¬ãŒïŒã§ããçä¹³æåãå°ãªãå Žåãã«ã«ã·ãŠã æåãåé¡ã«ãªããŸãããã«ã«ã·ãŠã æåã«ã¯ç乳以å€ã«ã¯ãkaleïŒã±ãŒã«ãã¢ãã©ãç§ã®éèïŒããããã³ãªãŒãè±è ããããé¡ãè±é¡ã匷åïŒfortifiedïŒãªã¬ã³ãžãžã¥ãŒã¹ãªã©ã§ãæåå¯èœã§ãããã¿ãã³Dã¯ãµããªã§è£å ã§ããŸãã
8. çä¹³äžèæ§å
ã¯è±ä¹³ã§ã¢ã¬ã«ã®ãŒçç¶ãæ¹åãã
ã幌å
ã®4ïŒ
ã§çä¹³èçœã®ã¢ã¬ã«ã®ãŒããããåæ¯ã湿ç¹ãé£ç©ã¢ã¬ã«ã®ãŒãçŸããŸããçä¹³äžèæ§å
65人ã®ãã¡44人ã¯è±ä¹³ïŒsoy milkïŒã«ããè£èãå«ããŠçç¶ãæ¹åããŸããã